Recap: Fulgent Genetics Q4 Earnings - Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics FLGT reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Fulgent Genetics beat estimated earnings by 33.33%, reporting an EPS of $3.48 versus an estimate of $2.61.

Revenue was up $43.31 million from the same period last year.

Last quarter the company beat on EPS by $0.8 which was followed by a 1.08% increase in the share price the next day.

Here's a look at Fulgent Genetics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	3.25	2.81	5.86	4.05
EPS Actual	4.05	2.55	6.59	6.20
Revenue Estimate	264.00M	197.34M	321.51M	199.44M
Revenue Actual	227.87M	153.62M	359.43M	294.98M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.